Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

BioAtla

BioAtla is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 1 service area.

View BioAtla on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Antibodies

  • Custom Antibodies Design and produce polyclonal and monoclonal antibodies.

In Vitro Assays

  • Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression

Protein Sciences

  • Protein Products Find native and recombinant proteins and peptides.

Service areas:

Biology

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States San Diego 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

BioAtla has deep expertise in the evolution and engineering of antibodies and other biologics for therapeutics. We employ proprietary technologies to solve critical protein development challenges including expression and function, and produce novel, IP-protectable products both for our clients and for our proprietary product portfolio. The culmination of our technological capabilities is our platform for engineering Conditionally Active Biologics (CAB's). CAB technology improves antibody selectivity for tumor tissue even when the antigen is also present in normal tissue, improving safety...

Show the full description

BioAtla has deep expertise in the evolution and engineering of antibodies and other biologics for therapeutics. We employ proprietary technologies to solve critical protein development challenges including expression and function, and produce novel, IP-protectable products both for our clients and for our proprietary product portfolio.

The culmination of our technological capabilities is our platform for engineering Conditionally Active Biologics (CAB's). CAB technology improves antibody selectivity for tumor tissue even when the antigen is also present in normal tissue, improving safety and therapeutic index and expanding the universe of potential therapeutic targets.

With labs in San Diego and Beijing, Bioatla works around the clock to efficiently and cost-effectively deliver on programs for our clients (pharma, biotechs, and academic researchers).

BioAtla Capabilities and Technologies

  • Antibody Cloning
  • Improved Antibody Expression
  • Express Humanization
  • Functional Maturation
  • Affinity
  • Cross-species Reactivity
  • Half-life
  • Internalization
  • Conditionally Active Biologics (CAB)
  • Intellectual Property

+Downloads+
BioAtla Brochure

Professional associations
BIOCOM
Website
www.bioatla.com

Source: Scientist.com supplier network, written by the supplier

Get the BioAtla report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with BioAtla on Scientist.com

For prices, more details, or to contact BioAtla, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.